Ascendis Pharma AS
Biotechnology
Healthcare
ASND
59.76 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
178.22
52 week high
179.10
high
179.20
52 week low
119.51
low
166.84
growth
45.11 %
previous Close
179.10
P/E ratio
-101
market cap
8.16 B
div yield
0
net incoming
-99.20 M
9.31 %
net profit margin
-171.52 %
132.00 %
operating incoming
-96.74 M
27.40 %
net change in cash
0.00 %
cash on hand
626 M
141.80 %
cost of revenue
11.20 M
-2.30 %
top